arrow
S

Sandra Manceau

universite paris cite
H指数:13
被引数:529

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MMS22L is a novel key actor of normal and pathological erythropoiesis
2025-12-230
OAAI
Base editing of β0-thalassemia mutations as a therapeutic strategy for severe β-hemoglobinopathies

β0-地中海贫血突变的碱基编辑作为一种治疗严重β-血红蛋白病的策略

2025-11-260
PRE
Protein S Enhances the Phagocytosis of Phosphatidylserine-Exposing Erythrocytes: Implications in Sickle Cell Disease

蛋白S增强暴露磷脂酰丝氨酸的红细胞的吞噬作用:在镰状细胞病中的意义

2025-10-250
OAAI
Severe inflammation and lineage skewing are associated with poor engraftment of engineered hematopoietic stem cells in patients with sickle cell disease

严重炎症和谱系偏移与 sickle cell disease 患者中工程化造血干细胞的植入不良相关。

2025-04-010
OA
Protein S Enhances the Phagocytosis of Phosphatidylserine-Positive Erythrocyte: Implications for the Erythrocytes Turnover

蛋白S增强磷脂酰丝氨酸阳性红细胞的吞噬作用:对红细胞周转的启示

BLOOD
IF23.1
2024-11-050
PRE
Clearance of pathogenic erythrocytes is maintained despite spleen dysfunction in children with sickle cell disease
2024-09-171
OAAI
Erythrocytic vacuoles that accumulate a fluorescent dye predict spleen size and function in sickle cell disease
2022-09-036
OA
Arterio-venous fistula for automated red blood cells exchange in patients with sickle cell disease: Complications and outcomes
2016-12-0717
OAAI